恒生创新药ETF（159316）涨2.65%，资金持续涌入！机构看好其高性价比的配置窗口

格隆汇2025-09-01

恒生创新药板块上涨，信达生物涨超8%，带动恒生创新药ETF（159316）涨2.65%。今年以来，创新药领涨市场，自4月9日以来，恒生创新药ETF（159316）涨超85%。恒生创新药ETF（159316）是市场唯一跟踪恒生港股通创新药指数的ETF产品，近60日获得15.41亿元资金净流入，最新规模18.79亿元。 8月11日，恒生港股通创新药指数正式调整生效，通过在编制方案中剔除CXO，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2564867231?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-01 11:28","share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","id":"2564867231","market":"sh","top_or_hot":-1,"title":"恒生创新药ETF（159316）涨2.65%，资金持续涌入！机构看好其高性价比的配置窗口","media":"格隆汇","content":"<div>\n<p>恒生创新药板块上涨，信达生物涨超8%，带动恒生创新药ETF（159316）涨2.65%。\n今年以来，创新药领涨市场，自4月9日以来，恒生创新药ETF（159316）涨超85%。\n恒生创新药ETF（159316）是市场唯一跟踪恒生港股通创新药指数的ETF产品，近60日获得15.41亿元资金净流入，最新规模18.79亿元。 \n8月11日，恒生港股通创新药指数正式调整生效，通过在编制方案中剔除CXO，...</p>\n\n<a href=\"https://www.gelonghui.com/rss/live/live.xml\">网页链接</a>\n\n</div>\n","source":"live_gelonghui","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒生创新药ETF（159316）涨2.65%，资金持续涌入！机构看好其高性价比的配置窗口</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒生创新药ETF（159316）涨2.65%，资金持续涌入！机构看好其高性价比的配置窗口\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-01 11:28 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.gelonghui.com/rss/live/live.xml><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>恒生创新药板块上涨，信达生物涨超8%，带动恒生创新药ETF（159316）涨2.65%。\n今年以来，创新药领涨市场，自4月9日以来，恒生创新药ETF（159316）涨超85%。\n恒生创新药ETF（159316）是市场唯一跟踪恒生港股通创新药指数的ETF产品，近60日获得15.41亿元资金净流入，最新规模18.79亿元。 \n8月11日，恒生港股通创新药指数正式调整生效，通过在编制方案中剔除CXO，...</p>\n\n<a href=\"https://www.gelonghui.com/rss/live/live.xml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.gelonghui.com/rss/live/live.xml","article_id":"2564867231","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564867231","pubTimestamp":1756697331,"columns":[],"sourceInfo":{"source_id":"live_gelonghui","name":"格隆汇"},"weMediaInfo":null,"summary":"恒生创新药板块上涨，信达生物涨超8%，带动恒生创新药ETF（159316）涨2.65%。\n今年以来，创新药领涨市场，自4月9日以来，恒生创新药ETF（159316）涨超85%。\n恒生创新药ETF（15","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159316":"创新药E","159858":"创新药指","159992":"创新药","515120":"创新药ETF","600109":"国金证券","BK4588":"碎股","BK0188":"融资融券","BK0012":"证金概念","BK4614":"Manus概念股","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","BK0028":"国家队","BK0276":"资本市场","BK1589":"北水核心资产","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","BK1161":"生物科技","BK7095":"多种金属与采矿","YANG":"三倍做空富时中国ETF-Direxion","CXO.AU":"CORE LITHIUM LTD","01801":"信达生物","07226":"南方两倍做多恒科","BK7504":"锂钴概念","HSCEI":"国企指数","BK4585":"ETF&股票定投概念","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","BK1574":"生物医药B类股","BK1583":"高瓴概念","HSTECH":"恒生科技指数","BK0183":"MSCI概念","BK0201":"可转债","FDN":"First Trust Dow Jones Internet I","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","CXO":"康休","06978":"永泰生物-B","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","BK4550":"红杉资本持仓","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC"},"translate_title":"Hang Seng Innovative Drug ETF (159316) rose 2.65%, and funds continued to pour in! Institutions are optimistic about its cost-effective configuration window","themeId":"82902c950c26b9e099be3b2ea5e92ba0","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159316":1,"159858":1,"159992":1,"515120":1,"600109":1,"06978":1,"07226":1,"YANG":1,"CXO.AU":1,"01801":1,"CXO":1,"FDN":1,"HSCEI":1,"HSTECH":1},"content_text":"恒生创新药板块上涨，信达生物涨超8%，带动恒生创新药ETF（159316）涨2.65%。\n今年以来，创新药领涨市场，自4月9日以来，恒生创新药ETF（159316）涨超85%。\n恒生创新药ETF（159316）是市场唯一跟踪恒生港股通创新药指数的ETF产品，近60日获得15.41亿元资金净流入，最新规模18.79亿元。 \n8月11日，恒生港股通创新药指数正式调整生效，通过在编制方案中剔除CXO，成为首批“纯度”100%的创新药指数，更加精准地反映我国创新药企的整体表现。根据模拟测算，剔除CXO后指数历史业绩将得到明显提升，指数发布日以来，修订版方案的指数业绩分别较原指数提升30%。\n国金证券认为，在全球医药产业持续革新的浪潮中，创新药板块正逐步引起市场的高度关注，港股创新药行业的核心投资价值源于估值历史低位与基本面加速改善的错配，形成较高性价比的配置窗口。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2564867231","isCrawlerRequest":true}